Amyotrophic lateral sclerosis

EL Feldman, SA Goutman, S Petri, L Mazzini… - The Lancet, 2022 - thelancet.com
Amyotrophic lateral sclerosis is a fatal CNS neurodegenerative disease. Despite intensive
research, current management of amyotrophic lateral sclerosis remains suboptimal from …

Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis

AE Volk, JH Weishaupt, PM Andersen… - Medizinische …, 2018 - degruyter.com
Die amyotrophe Lateralsklerose (ALS) ist die häufigste neurodegenerative Erkrankung des
motorischen Nervensystems. Ursächlich ist der Untergang des ersten und/oder zweiten …

The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients

Q Zeng, J Shen, K Chen, J Zhou, Q Liao, K Lu… - Scientific reports, 2020 - nature.com
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease accompanied with
severe paralysis or even death, while the pathogenesis of ALS is still unclear and no …

[图书][B] Klinische Elektromyographie und Neurographie: Lehrbuch und Atlas

M Stöhr, R Pfister, P Reilich - 2022 - books.google.com
Elektromyographie und Elektroneurographie sind die unverzichtbare Erweiterung der
klinisch-neurologischen Diagnostik im täglichen Einsatz in neurologischen Kliniken und …

Prognostic factors in ALS: a comparison between Germany and China

J Dorst, L Chen, A Rosenbohm, J Dreyhaupt… - Journal of …, 2019 - Springer
Objective Several independent prognostic factors, such as age of onset, type of onset, body
mass index (BMI), and progression rate have been identified for amyotrophic lateral …

Multimodal assessment of autonomic dysfunction in amyotrophic lateral sclerosis

D Weise, I Menze, MCF Metelmann… - European Journal of …, 2022 - Wiley Online Library
Background and purpose Amyotrophic lateral sclerosis (ALS) is a neurodegenerative
disorder with predominant progressive degeneration of motor neurons and motor deficits …

Cortical circuit dysfunction as a potential driver of amyotrophic lateral sclerosis

A Brunet, G Stuart-Lopez, T Burg… - Frontiers in …, 2020 - frontiersin.org
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease that affects
selected cortical and spinal neuronal populations, leading to progressive paralysis and …

Fast versus slow disease progression in amyotrophic lateral sclerosis–clinical and genetic factors at the edges of the survival spectrum

S Witzel, M Wagner, C Zhao, K Kandler, E Graf… - Neurobiology of …, 2022 - Elsevier
Patients with amyotrophic lateral sclerosis (ALS) show substantial differences in disease
progression and survival. However, the genetic contribution to the extremes of this spectrum …

Safety of intrathecal injection of Wharton's jelly-derived mesenchymal stem cells in amyotrophic lateral sclerosis therapy

M Barczewska, M Grudniak… - Neural Regeneration …, 2019 - journals.lww.com
Animal experiments have confirmed that mesenchymal stem cells can inhibit motor neuron
apoptosis and inflammatory factor expression and increase neurotrophic factor expression …

Care pathway heterogeneity in Amyotrophic Lateral Sclerosis: effects of gender, age and onset

M Dibling, J Ortholand, F Salachas, A Hesters… - …, 2024 - karger.com
Background and objectives: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative
disease characterized by progressive motor neuron degeneration resulting in loss of muscle …